Published online Jan 28, 2022. doi: 10.3748/wjg.v28.i4.449
Peer-review started: April 18, 2021
First decision: June 3, 2021
Revised: June 16, 2021
Accepted: January 11, 2022
Article in press: January 11, 2022
Published online: January 28, 2022
Processing time: 278 Days and 22.6 Hours
Core Tip: Currently identified genes account only for half of celiac disease (CeD) predisposition. An important role could be played by epigenetics, inheritable traits without DNA sequence alterations, which could be influenced by gluten exposure. DNA methylation, histone modifications and non-coding RNAs act on different gene expression steps, from gene transcription to post-translational ones. Epigenetic changes can be additional predisposition factors or specific of CeD stages (active disease, gluten-free diet) as recently reported. Analysis of epigenetic data and their integration with transcriptome (by machine learning) can help to stratify patients, or discover new players in CeD pathogenesis, possible focus of novel therapeutic approaches.
